Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Hong

Showing results (181-190 of 306) with videos related to

Pageof 31
Sort By:
Practical Radiation Oncology|February 29, 2016
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness MethodKaryn A Goodman, Caroline E Patton, George A Fisher, et al.
Histopathology|February 8, 2020
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiationAzfar Neyaz, Elisabeth S Tabb, Angela Shih, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancerJennifer Y Wo, Harvey J Mamon, Cristina R Ferrone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2026
NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancerGeoffrey Y Ku, Kathryn Winter, David Ilson, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
Pancreas|May 21, 2021
Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective StudyGrace Lee, Daniel W Kim, Oluwadamilola T Oladeru, et al.
Cancer|September 6, 2013
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010Sophie Cai, Theodore S Hong, Saveli I Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
European Radiology|October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapyYoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Annals of Surgery|September 13, 2012
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?Ioannis T Konstantinidis, Andrew L Warshaw, Jill N Allen, et al.
Pageof 31

Showing results (181-190 of 306) with videos related to

Sort By:
Pageof 31
Practical Radiation Oncology|February 29, 2016
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness MethodKaryn A Goodman, Caroline E Patton, George A Fisher, et al.
Histopathology|February 8, 2020
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiationAzfar Neyaz, Elisabeth S Tabb, Angela Shih, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancerJennifer Y Wo, Harvey J Mamon, Cristina R Ferrone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2026
NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancerGeoffrey Y Ku, Kathryn Winter, David Ilson, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
Pancreas|May 21, 2021
Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective StudyGrace Lee, Daniel W Kim, Oluwadamilola T Oladeru, et al.
Cancer|September 6, 2013
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010Sophie Cai, Theodore S Hong, Saveli I Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
European Radiology|October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapyYoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Annals of Surgery|September 13, 2012
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?Ioannis T Konstantinidis, Andrew L Warshaw, Jill N Allen, et al.
Pageof 31